Evidence for endothelin-1-mediated vasoconstriction in severe chronic heart failure
- 1 September 1995
- journal article
- clinical trial
- Published by Elsevier in The Lancet
- Vol. 346 (8977) , 732-736
- https://doi.org/10.1016/s0140-6736(95)91504-4
Abstract
No abstract availableKeywords
This publication has 25 references indexed in Scilit:
- Clearance of Circulating Endothelin-1 by ETB Receptors in RatsBiochemical and Biophysical Research Communications, 1994
- Radioimmunological Determination of Endothelin Peptides in Human Plasma: A Methodological ApproachEndothelium, 1994
- Differences in vascular effects and removal of endothelin‐1 in human lung, brain, and skeletal muscle,Clinical Physiology and Functional Imaging, 1993
- Antihypertensive Effects of the Endothelin Receptor Antagonist BQ-123 in Conscious Spontaneously Hypertensive RatsJournal of Cardiovascular Pharmacology, 1993
- Metabolism and production of angiotensin I in different vascular beds in subjects with hypertension.Hypertension, 1990
- A novel potent vasoconstrictor peptide produced by vascular endothelial cellsNature, 1988
- Arterial vasodilator, systemic and coronary hemodynamic effects of nisoldipine in congestive heart failure secondary to ischemic or dilated cardiomyopathyThe American Journal of Cardiology, 1987
- Results of long-term vasodilator therapy in patients with refractory congestive heart failure.Circulation, 1981
- The obligatory role of endothelial cells in the relaxation of arterial smooth muscle by acetylcholineNature, 1980
- Measurement of angiotensin II in human plasma: Technical modifications and practical experienceClinica Chimica Acta; International Journal of Clinical Chemistry, 1976